Barinthus Biotherapeutics (BRNS) Statistics & Valuation Metrics - Stocknear

Barinthus Biotherapeutics

NASDAQ: BRNS · Real-Time Price · USD
1.21
-0.12 (-9.02%)
At close: Sep 05, 2025, 3:59 PM
1.22
0.57%
After-hours: Sep 05, 2025, 04:10 PM EDT

Barinthus Biotherapeutics Statistics

Share Statistics

Barinthus Biotherapeutics has 40.35M shares outstanding. The number of shares has increased by 2.95% in one year.

40.35M
2.95%
2.02%
n/a
37.21M
1,653
0.13%

Short Selling Information

The latest short interest is 12.32K, so 0.03% of the outstanding shares have been sold short.

12.32K
0.03%
0.05%
1

Valuation Ratios

The PE ratio is -0.78 and the forward PE ratio is -0.95. Barinthus Biotherapeutics's PEG ratio is 0.04.

-0.78
-0.95
3.18
66.3
0.37
-1.6
0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Barinthus Biotherapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.09.

8.03
8.03
0.09
-0.22
-0.4
-1282.45

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$142.56K
$-581.66K
105
0.09
n/a

Taxes

-44K
0.07%

Stock Price Statistics

The stock price has increased by -5.47% in the last 52 weeks. The beta is -0.74, so Barinthus Biotherapeutics's price volatility has been lower than the market average.

-0.74
-5.47%
1.26
1.03
49.93
1,252,216

Income Statement

In the last 12 months, Barinthus Biotherapeutics had revenue of 14.97M and earned -61.07M in profits. Earnings per share was -1.55.

14.97M
14.97M
-67.97M
-61.07M
-55.37M
-61.17M
-1.55
Full Income Statement

Balance Sheet

The company has 110.66M in cash and 12.01M in debt, giving a net cash position of 98.66M.

110.66M
12.01M
98.66M
-237.66M
129.56M
87.69M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.94M and capital expenditures -892K, giving a free cash flow of -29.83M.

-28.94M
-892K
-29.83M
-0.76
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -454.07% and -408%.

100%
-454.07%
-409.03%
-408%
-369.92%
-454.07%
-199.29%

Dividends & Yields

BRNS does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BRNS is $3, which is 147.9% higher than the current price. The consensus rating is "Buy".

$3
147.9%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-2.82
2